BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25721615)

  • 1. Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil.
    Wang BF; Wang Y; Wang BY; Sun FR; Zhang D; Chen YS
    J Clin Pharm Ther; 2015 Jun; 40(3):345-8. PubMed ID: 25721615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition.
    Wu C; Zhang H; Qian Y; Wang L; Gu X; Dai Z
    J Clin Pharm Ther; 2013 Aug; 38(4):321-6. PubMed ID: 23590583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report.
    Xiang Q; Liu Z; Yu Y; Zhang H; Xie Q; Mu G; Zhang J; Cen X; Cui Y
    BMC Pharmacol Toxicol; 2020 Jun; 21(1):43. PubMed ID: 32503675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity, including acquired Fanconi's syndrome, caused by adefovir dipivoxil - is there a safe dose?
    Law ST; Li KK; Ho YY
    J Clin Pharm Ther; 2012 Apr; 37(2):128-31. PubMed ID: 21714795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteomalacia due to Fanconi's syndrome and renal failure caused by long-term low-dose adefovir dipivoxil.
    Shimohata H; Sakai S; Ogawa Y; Hirayama K; Kobayashi M
    Clin Exp Nephrol; 2013 Feb; 17(1):147-8. PubMed ID: 23268286
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B.
    Eguchi H; Tsuruta M; Tani J; Kuwahara R; Hiromatsu Y
    Intern Med; 2014; 53(3):233-7. PubMed ID: 24492692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophosphataemic osteomalacia in patients on adefovir dipivoxil.
    Girgis CM; Wong T; Ngu MC; Emmett L; Archer KA; Chen RC; Seibel MJ
    J Clin Gastroenterol; 2011; 45(5):468-73. PubMed ID: 20661153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adefovir Dipivoxil-induced Fanconi's Syndrome and Osteomalacia Following Multiple Bone Fractures in a Patient with Chronic Hepatitis B].
    Makita T; Kanzaki H; Onishi H; Ikeda A; Takaki A; Wada N; Takeuchi Y; Yasunaka T; Ikeda F; Shiraha H; Tanaka Y; Nishihara S; Murakawa K; Kitamura Y; Okada H; Sendo T
    Yakugaku Zasshi; 2019; 139(4):641-645. PubMed ID: 30930400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired Fanconi syndrome associated with prolonged adefovir dipivoxil therapy in a chronic hepatitis B patient.
    Law ST; Li KK; Ho YY
    Am J Ther; 2013; 20(6):e713-6. PubMed ID: 21519215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report.
    Kunii T; Iijima T; Jojima T; Shimizu M; Kase M; Sakurai S; Kogai T; Usui I; Aso Y
    J Med Case Rep; 2019 Apr; 13(1):99. PubMed ID: 31003599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term observation of osteomalacia caused by adefovir-induced Fanconi's syndrome.
    Terasaka T; Ueta E; Ebara H; Waseda K; Hanayama Y; Takaki A; Kawabata T; Sugiyama H; Hidani K; Otsuka F
    Acta Med Okayama; 2014; 68(1):53-6. PubMed ID: 24553490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B].
    Li L; Dong GF; Zhang X; Xie YS
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1956. PubMed ID: 22126791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible?
    Qian YY; Dai ZJ; Ruan LY; Pan YJ; Jin J; Shi MT; Zhu YX; Wu CM
    Drug Des Devel Ther; 2019; 13():1127-1133. PubMed ID: 31118563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report.
    Tanaka M; Setoguchi T; Ishidou Y; Arishima Y; Hirotsu M; Saitoh Y; Nakamura S; Kakoi H; Nagano S; Yokouchi M; Kamizono J; Komiya S
    Diagn Pathol; 2012 Aug; 7():108. PubMed ID: 22906214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose adefovir dipivoxil may induce Fanconi syndrome: clinical characteristics and long-term follow-up for Chinese patients.
    Xu LJ; Jiang Y; Liao RX; Zhang HB; Mao JF; Chi Y; Li M; Wang O; Liu XQ; Liu ZY; Xing XP; Yu W; Xia WB
    Antivir Ther; 2015; 20(6):603-11. PubMed ID: 25814481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B.
    Lee YS; Kim BK; Lee HJ; Dan J
    Clin Orthop Surg; 2016 Jun; 8(2):232-6. PubMed ID: 27247753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fanconi's Syndrome Associated with Prolonged Adefovir Dipivoxil Therapy in a Hepatitis B Virus Patient.
    Jung YK; Yeon JE; Choi JH; Kim CH; Jung ES; Kim JH; Park JJ; Kim JS; Bak YT; Byun KS
    Gut Liver; 2010 Sep; 4(3):389-93. PubMed ID: 20981219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of the clinical characteristics of adefovir dipivoxil-induced Fanconi's syndrome in the Chinese population.
    Sun L; Yi D; Sun W; Wang C
    J Clin Pharm Ther; 2020 Aug; 45(4):722-728. PubMed ID: 32406123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency.
    Koda R; Tsuchida M; Iino N; Narita I
    Intern Med; 2019 Mar; 58(6):821-825. PubMed ID: 30333420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series.
    Chen N; Zhang JB; Zhang Q; Zhao YP; Li LY; Liu LW; Yu F; Yu X; Peng T; Tang KX
    BMC Pharmacol Toxicol; 2018 May; 19(1):23. PubMed ID: 29769119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.